Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Multi-Omics”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableLooking for participantsNCT06885619
What this trial is testing

Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

Who this might be right for
Left Ventricular RemodelingPlasma Multi-OmicsAcute ST-segment Elevation Myocardial Infarction+2 more
Beijing Anzhen Hospital 1,000
Not applicableLooking for participantsNCT07113769
What this trial is testing

Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation

Who this might be right for
ExtraCorporeal Membrane Oxygenation (ECMO)Cardiac Arrest
Central China Fuwai Hospital of Zhengzhou University 130
Not applicableLooking for participantsNCT07445438
What this trial is testing

Feasibility of a Multi-omics Platform for Hematological Malignancies

Who this might be right for
Myeloma MultipleChronic LeukemiaAcute Leukemia+3 more
Azienda Ospedaliero-Universitaria di Parma 1,040
Not applicableUnknownNCT04993378
What this trial is testing

Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy

Who this might be right for
Advanced Gastric AdenocarcinomaImmunotherapy
Shen Lin 40
Not applicableUnknownNCT05587452
What this trial is testing

Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence

Who this might be right for
Colorectal AdenomaColorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 950
Not applicableLooking for participantsNCT07403630
What this trial is testing

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Who this might be right for
Acute LeukemiaMultiple MyelomaSquamous Cell Carcinoma+9 more
Azienda Ospedaliero-Universitaria di Parma 300
Not applicableActive Not RecruitingNCT07492238
What this trial is testing

Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cancer Conversion Therapy

Who this might be right for
Colorectal Cancer
Xiujuan Qu 120
Not applicableStudy completedNCT05123001
What this trial is testing

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Who this might be right for
Hodgkin LymphomaNon Hodgkin LymphomaLeukemia+1 more
Stanford University 11
Not applicableUnknownNCT04947995
What this trial is testing

Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer

Who this might be right for
Gastric Cancer
GeneCast Biotechnology Co., Ltd. 450
Not applicableEnrolling By InvitationNCT06730477
What this trial is testing

Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaEGFR Activating Mutation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 500
Not applicableLooking for participantsNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Not applicableUnknownNCT04678089
What this trial is testing

Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics

Who this might be right for
Multiple MyelomaBortezomib
Beijing Chao Yang Hospital 350